These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23792586)

  • 1. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.
    Grugan KD; Vega ME; Wong GS; Diehl JA; Bass AJ; Wong KK; Nakagawa H; Rustgi AK
    Cancer Biol Ther; 2013 Sep; 14(9):853-9. PubMed ID: 23792586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.
    Grugan KD; Miller CG; Yao Y; Michaylira CZ; Ohashi S; Klein-Szanto AJ; Diehl JA; Herlyn M; Han M; Nakagawa H; Rustgi AK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11026-31. PubMed ID: 20534479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
    Okawa T; Michaylira CZ; Kalabis J; Stairs DB; Nakagawa H; Andl CD; Johnstone CN; Klein-Szanto AJ; El-Deiry WS; Cukierman E; Herlyn M; Rustgi AK
    Genes Dev; 2007 Nov; 21(21):2788-803. PubMed ID: 17974918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
    Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
    Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-canonical p53 signaling to promote invasion.
    Dent P
    Cancer Biol Ther; 2013 Oct; 14(10):879-80. PubMed ID: 24025254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
    Dong P; Xu Z; Jia N; Li D; Feng Y
    Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
    Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
    Saito S; Morishima K; Ui T; Hoshino H; Matsubara D; Ishikawa S; Aburatani H; Fukayama M; Hosoya Y; Sata N; Lefor AK; Yasuda Y; Niki T
    BMC Cancer; 2015 Feb; 15():82. PubMed ID: 25884729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma.
    Lehman HL; Yang X; Welsh PA; Stairs DB
    Am J Pathol; 2015 Jan; 185(1):240-51. PubMed ID: 25529795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.
    Xu Y; Peng Z; Li Z; Lu M; Gao J; Li Y; Li Y; Shen L
    BMC Cancer; 2015 Jan; 15():6. PubMed ID: 25588551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma.
    Long A; Giroux V; Whelan KA; Hamilton KE; Tétreault MP; Tanaka K; Lee JS; Klein-Szanto AJ; Nakagawa H; Rustgi AK
    Carcinogenesis; 2015 May; 36(5):598-606. PubMed ID: 25795715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.
    Wang L; Xing J; Cheng R; Shao Y; Li P; Zhu S; Zhang S
    PLoS One; 2015; 10(5):e0126319. PubMed ID: 25950810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma.
    Li JC; Zhao YH; Wang XY; Yang Y; Pan DL; Qiu ZD; Su Y; Pan JJ
    Tumour Biol; 2014 Jan; 35(1):651-7. PubMed ID: 24052437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
    Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
    Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
    Rieber M; Strasberg Rieber M
    Int J Cancer; 2009 Oct; 125(7):1604-12. PubMed ID: 19507255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.